A post-translational mechanism coupling cell-cycle entry to membrane and mitochondrial capacity is defined, and the cost of uncoupling this program from its metabolic support is revealed.
Sharon Kaisari, Ethan Lane, Raymond Wang et al.· bioRxiv· 0 citations
Lung squamous cell carcinoma (LUSC) is an aggressive subtype of non-small cell lung cancer with limited targeted therapeutic options and incompletely defined immune-regulatory dependencies. Here, we identified atypical chemokine receptor 3 (ACKR3) as a squamous-enriched regulator that restrains malignant progression in...
Angeliki Karatza, Kaan Kumru, Jaylen M. Powell et al.· Cancer Research· 0 citations
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer characterized by profound desmoplasia and cellular heterogeneity, which cannot be fully resolved using traditional bulk sequencing approaches. To understand how this heterogeneity contributes to PDAC biology, we analyzed a large cohort of primary tumors...
Despoina Kalfakakou, Sungsik Kim, Li-Dong Wang et al.· Cancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.